ATE447858T1 - Pharmazeutische zusammensetzung für muskelanabolismus - Google Patents

Pharmazeutische zusammensetzung für muskelanabolismus

Info

Publication number: ATE447858T1
Authority: AT; Austria
Prior art keywords: anabolic; pharmaceutical composition; initiators; denatured; muscle anabolism
Prior art date: 2000-02-10

Application number

AT01910231T

Other languages

English (en)

Inventor

Rudolf Smeets

Robert Hageman

Original Assignee

Nutricia Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-02-10

Filing date

2001-02-12

Publication date

2009-11-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23990994&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE447858(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2001-02-12 Application filed by Nutricia Nv filed Critical Nutricia Nv

2009-11-15 Application granted granted Critical

2009-11-15 Publication of ATE447858T1 publication Critical patent/ATE447858T1/de

Links

230000015572 biosynthetic process Effects 0.000 title abstract 2
239000008194 pharmaceutical composition Substances 0.000 title abstract 2
210000003205 muscle Anatomy 0.000 title 1
230000001195 anabolic effect Effects 0.000 abstract 5
CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 abstract 2
239000003999 initiator Substances 0.000 abstract 2
235000021120 animal protein Nutrition 0.000 abstract 1
229960003624 creatine Drugs 0.000 abstract 1
239000006046 creatine Substances 0.000 abstract 1
230000002708 enhancing effect Effects 0.000 abstract 1
239000003102 growth factor Substances 0.000 abstract 1
230000003387 muscular Effects 0.000 abstract 1
235000018102 proteins Nutrition 0.000 abstract 1
102000004169 proteins and genes Human genes 0.000 abstract 1
108090000623 proteins and genes Proteins 0.000 abstract 1
239000000758 substrate Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/20—Milk; Whey; Colostrum
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/19—Dairy proteins
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
- Y10S530/829—Blood
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
- Y10S530/832—Milk; colostrum
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
- Y10S530/833—Whey; cheese

Landscapes

Life Sciences & Earth Sciences (AREA)
Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Polymers & Plastics (AREA)
Food Science & Technology (AREA)
Nutrition Science (AREA)
Mycology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Immunology (AREA)
Virology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Zoology (AREA)
Developmental Biology & Embryology (AREA)
Cell Biology (AREA)
Biotechnology (AREA)
Biomedical Technology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

AT01910231T 2000-02-10 2001-02-12 Pharmazeutische zusammensetzung für muskelanabolismus ATE447858T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US09/500,802 US6521591B1 (en)	2000-02-10	2000-02-10	Pharmaceutical composition for muscular anabolism
PCT/NL2001/000112 WO2001058284A1 (en)	2000-02-10	2001-02-12	Pharmaceutical composition for muscular anabolism

Publications (1)

Publication Number	Publication Date
ATE447858T1 true ATE447858T1 (de)	2009-11-15

Family

ID=23990994

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT01910231T ATE447858T1 (de)	2000-02-10	2001-02-12	Pharmazeutische zusammensetzung für muskelanabolismus

Country Status (9)

Country	Link
US (1)	US6521591B1 (de)
EP (1)	EP1253830B1 (de)
AT (1)	ATE447858T1 (de)
AU (2)	AU2001237809B2 (de)
CA (1)	CA2398990C (de)
DE (1)	DE60140426D1 (de)
ES (1)	ES2336764T3 (de)
HK (1)	HK1048050B (de)
WO (1)	WO2001058284A1 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE10032964B4 (de) *	2000-07-06	2017-10-12	Beiersdorf Ag	Verwendung von Kreatin in kosmetischen oder dermatologischen Zubereitungen
US7744930B2 (en) *	2002-11-22	2010-06-29	Shaklee Corporation	Compositions, methods and kits for enhancing weight loss while inhibiting loss of lean body mass
US7288570B2 (en) *	2002-12-20	2007-10-30	Nutricia N.V.	Stimulation of in vivo production of proteins
US20050143343A1 (en) *	2003-12-30	2005-06-30	Nerenberg Arnold P.	Nutritional supplement for enhancing the production and effect of natural human growth hormone
MXPA06009377A (es) *	2004-02-20	2007-03-07	Lifescape Biosciences Inc	Composiciones y metodos para regulacion del sueno.
US20050215640A1 (en)	2004-03-26	2005-09-29	Baxter Jeffrey H	HMB compositions and uses thereof
US20060013889A1 (en) *	2004-07-16	2006-01-19	Playford Raymond J	Colostrum-based treatment for irritable bowel syndrome
MX2007002209A (es) *	2004-08-25	2007-11-08	Multi Formulations Ltd	Composiciones y metodos para activar la sintesis de proteinas y para desactivar procesos de catabolicos dentro del musculo esqueletico.
US7426440B2 (en) *	2004-09-24	2008-09-16	Nutritional Bioscience Ltd.	Repair and protection factor scoring method for bioactive agents
US20060068022A1 (en) *	2004-09-29	2006-03-30	Playford Raymond J	Bioactive agent compositions for repair of cell injuries
CA2537647A1 (en) *	2005-03-01	2006-09-01	Six Star Formulations Ltd.	Supplemental dietary composition for supporting muscle growth, recovery and strength
DE102005028446A1 (de) *	2005-06-17	2006-12-28	Sibylle E. Bauer	Zusammensetzung, insbesondere Nahrungsergänzungsmittel
US20080317886A1 (en) *	2005-11-03	2008-12-25	Sparkman Dennis R	Compositions for Preventing and Reducing Delayed Onset Muscle Soreness
ES2548432T3 (es) *	2005-12-19	2015-10-16	Abbott Laboratories	Uso de beta-hidroxi-beta-metilbutirato para modular el desequilibrio en la producción de citoquinas de tipo 1 y tipo 2
CN101524155B (zh) *	2009-04-20	2012-10-10	北京康比特体育科技股份有限公司	一种氨基酸组合物
SG182812A1 (en)	2010-01-29	2012-09-27	Abbott Lab	Nutritional emulsions comprising calcium hmb
TWI519242B (zh) *	2010-01-29	2016-02-01	亞培公司	包含鈣ｈｍｂ及可溶性蛋白質的營養乳劑
BR112012018642A2 (pt) *	2010-01-29	2015-09-01	Abbott Lab	Pos nutricionais compreendendo hmb seco por pulverizacao
WO2011094548A1 (en)	2010-01-29	2011-08-04	Abbott Laboratories	Aseptically packaged nutritional liquids comprising hmb
US9693577B2 (en)	2010-01-29	2017-07-04	Abbott Laboratories	Method of preparing a nutritional powder comprising spray dried HMB
CN101791127B (zh) *	2010-03-05	2012-07-18	北京康比特体育科技股份有限公司	一种含有HMβ的肌肉保护组合物
TWI526161B (zh)	2010-06-10	2016-03-21	亞培公司	包含鈣ｈｍｂ及可溶性蛋白質之實質上透明營養液
ES2633360T3 (es)	2014-04-02	2017-09-20	Alzchem Ag	Matriz de creatina y proteínas así como procedimiento para la producción de esta matriz
AU2017217466A1 (en)	2016-02-11	2018-08-23	Nutrition 21, Llc	Chromium containing compositions for improving health and fitness
JOP20190146A1 (ar)	2016-12-19	2019-06-18	Axcella Health Inc	تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
WO2019036471A1 (en)	2017-08-14	2019-02-21	Axcella Health Inc.	AMINO ACIDS BRANCHED FOR THE TREATMENT OF LIVER DISEASE
EP3810123A1 (de)	2018-06-20	2021-04-28	Axcella Health Inc.	Zusammensetzungen und verfahren zur behandlung von fettinfiltration in muskeln
TWI737987B (zh) *	2019-04-23	2021-09-01	豐華生物科技股份有限公司	一種乳酸菌菌株在製備提升運動能力與抗疲勞之組合物之用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5036052A (en) *	1988-06-22	1991-07-30	Morishita Pharmaceutical Co., Ltd.	Amino acid nutrient compositions
US5726146A (en) *	1994-12-06	1998-03-10	Natural Supplement Association, Incorporated	Non-steroidal, anabolic dietary supplement and method to increase lean mass without linked increase fat mass
DE69814834T2 (de)	1997-03-27	2004-04-08	Sole, Michael J., Toronto	Ernährungszusammensetzung zur verbesserung der zellenenergie
EP0875155A1 (de)	1997-05-01	1998-11-04	N.V. Nutricia	Perioperatives Getränk
AUPP327198A0 (en) *	1998-04-30	1998-05-21	Northfield Laboratories Pty Ltd	A food composition and method of using same
EP1094824B1 (de)	1998-06-10	2006-04-05	Albert B. Crum	Vorbeugender und therapeutischer nahrungsmittelzusatz zur schaffung/erhaltung einer die gesundheit schützenden darmmikroflora und zur stärkung des immunsystems

2000
- 2000-02-10 US US09/500,802 patent/US6521591B1/en not_active Expired - Lifetime
2001
- 2001-02-12 DE DE60140426T patent/DE60140426D1/de not_active Expired - Lifetime
- 2001-02-12 WO PCT/NL2001/000112 patent/WO2001058284A1/en not_active Ceased
- 2001-02-12 ES ES01910231T patent/ES2336764T3/es not_active Expired - Lifetime
- 2001-02-12 HK HK03100252.0A patent/HK1048050B/en not_active IP Right Cessation
- 2001-02-12 AU AU2001237809A patent/AU2001237809B2/en not_active Ceased
- 2001-02-12 AT AT01910231T patent/ATE447858T1/de not_active IP Right Cessation
- 2001-02-12 CA CA2398990A patent/CA2398990C/en not_active Expired - Fee Related
- 2001-02-12 EP EP01910231A patent/EP1253830B1/de not_active Revoked
- 2001-02-12 AU AU3780901A patent/AU3780901A/xx active Pending

Also Published As

Publication number	Publication date
ES2336764T3 (es)	2010-04-16
AU2001237809B2 (en)	2005-04-07
HK1048050B (en)	2009-12-31
US6521591B1 (en)	2003-02-18
DE60140426D1 (de)	2009-12-24
EP1253830B1 (de)	2009-11-11
AU3780901A (en)	2001-08-20
WO2001058284A1 (en)	2001-08-16
CA2398990C (en)	2013-04-02
CA2398990A1 (en)	2001-08-16
HK1048050A1 (en)	2003-03-21
EP1253830A1 (de)	2002-11-06

Legal Events

Date	Code	Title	Description
2010-05-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
DE60140426D1 (de)	2009-12-24	Pharmazeutische zusammensetzung für muskelanabolismus
BR0214343A (pt)	2004-09-14	Inibidores de 11 - beta - hidroxi esteróide desidrogenase tipo 1
SE0001899D0 (sv)	2000-05-22	New compounds
NZ515902A (en)	2004-02-27	Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, and type 2 diabetes
MY148480A (en)	2013-04-30	Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
DE50015623D1 (de)	2009-05-28	Kovalent verbrückte insulindimere
PL343771A1 (en)	2001-09-10	N-substituted aminotetralins as ligands for the neuropeptide y y5 receptor useful in the treatment of obesity and other disorders
BRPI0514420A (pt)	2008-06-10	peptìdeo, variante do mesmo, ou um sal farmaceuticamente aceitável do mesmo, composição, uso de um peptìdeo ou de uma variante de peptìdeo, substrato, e, métodos de tratamento ou prevenção de um infecção microbiana, e de tratamento de uma ferida em um indivìduo
CY1111470T1 (el)	2015-08-05	Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α
CY1107146T1 (el)	2012-05-23	Μεθοδοι για προληψη και θεραπεια ασθενειας alzheimer (ad)
EP1670450B8 (de)	2011-03-23	Pharmazeutische zusammensetzungen und verfahren zur verwendung von levodopa und carbidopa
GB0222514D0 (en)	2002-11-06	Organic compounds
ATE433959T1 (de)	2009-07-15	Analoge von kokain
PT1506185E (pt)	2006-10-31	Compostos novos e sua utilizacao
NZ547587A (en)	2009-09-25	Pharmaceutical compositions and methods for insulin treatment
IT1299583B1 (it)	2000-03-16	Uso di proteine hmg-i per la preparazione di medicamenti ad attivita' citotossica
DE60015508T2 (de)	2005-04-21	C-16 ungesätigte fp-selektive prostaglandin analoge
TW200503666A (en)	2005-02-01	Treatment of type 1 diabetes with pde5 inhibitors
ITRM20030596A1 (it)	2005-06-24	Uso di inibitori della pentraxina lunga ptx3, per la preparazione di un medicamento per la prevenzione e cura di patologie che rispondono all'inibizione dell'attivita' biologica di detta ptx3.
WO2005056520A8 (en)	2005-09-15	Somatostatin receptor subtype 1 (sstr1) active compounds and their use in therapy
CY1105142T1 (el)	2009-11-04	Χρηση υποκατεστημενων ενωσεων 6-διμεθυλαμινομεθυλο-1-φαινυλο-κυκλοεξανιου για τη θepαπεια της ακρατειας ουρων
EP1813289A4 (de)	2007-12-05	Medizinische zusammensetzung zur behandlung von krebs oder diabetes
EP1260221A3 (de)	2002-12-18	Kombinationsbehandlung für Depression und Angstzustände
AU2001274138A1 (en)	2001-12-17	Propanolaminotetralines, preparation thereof and compositions containing same
DE60216090D1 (de)	2006-12-28	Verwendung von l-acetylcarnitin zur herstellung eines medikaments zur behandlung von anhedonia